{"annotatable":{"parts":["s1v1","s2v1","s3v1","s4v1","s5v1","s6v1","s7v1","s8v1","s9v1","s10v1","s11v1","s12v1","s13v1"]},"anncomplete":true,"sources":[],"metas":{"m_82":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_83":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_84":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_85":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_86":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_35":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}}},"entities":[{"classId":"e_126","part":"s2v1","offsets":[{"start":969,"text":"The study was randomised, double-blind, placebo-controlled with  the  objective  to  evaluate  the  efficacy  of  Lactobacil-lus plantarum HEAL9 and Lactobacillus paracasei 8700:2 as compared to placebo"}],"coordinates":[{"x":"51.02","y":"321.14"},{"x":"146.62","y":"365.26"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_192","part":"s2v1","offsets":[{"start":983,"text":"randomised, double-blind"}],"coordinates":[{"x":"109.35","y":"321.14"},{"x":"210.47","y":"327.76"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_131","part":"s2v1","offsets":[{"start":995,"text":"double-blind"}],"coordinates":[{"x":"160.02","y":"321.14"},{"x":"210.47","y":"327.76"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_176","part":"s2v1","offsets":[{"start":1180,"text":"incidence of upper respira-tory tract infections (URTIs) in children attending day care"}],"coordinates":[{"x":"179.90","y":"358.64"},{"x":"286.57","y":"377.76"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_217","part":"s2v1","offsets":[{"start":1461,"text":"ClinicalTrials.gov  (number  NCT01935986)"}],"coordinates":[{"x":"106.38","y":"421.14"},{"x":"289.10","y":"427.76"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_210","part":"s2v1","offsets":[{"start":1482,"text":"number  NCT01935986"}],"coordinates":[{"x":"188.82","y":"421.14"},{"x":"285.58","y":"427.76"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s3v1","offsets":[{"start":1422,"text":"The children were randomly allocated to receive probiotic product or placebo based on a computer-generated  randomization  list  with  blocks  of  four."}],"coordinates":[{"x":"120.51","y":"370.26"},{"x":"257.87","y":"401.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_113","part":"s3v1","offsets":[{"start":1576,"text":"Sealed envelopes were prepared for the allocation concealment and were safely stored by the principal investigator, throughout the study. The labelling of the study product and the prepara-tion of the sealed code envelopes was done by employees at Probi not otherwise involved in any study-related activities."}],"coordinates":[{"x":"261.35","y":"395.26"},{"x":"289.07","y":"464.38"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_186","part":"s3v1","offsets":[{"start":1893,"text":"The primary objective of the study was to show the ben-efit from using the probiotic combination as compared to placebo, on the incidence of upper respiratory infections during the intervention period of 90 days. Incidence was defined  as  the  number  of  children  repor ting  at  least  one infection."}],"coordinates":[{"x":"51.02","y":"507.76"},{"x":"91.48","y":"576.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_211","part":"s3v1","offsets":[{"start":2021,"text":"incidence of upper respiratory infections"}],"coordinates":[{"x":"118.36","y":"532.76"},{"x":"289.31","y":"539.38"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_180","part":"s3v1","offsets":[{"start":2106,"text":"Incidence was defined  as  the  number  of  children  repor ting  at  least  one infection"}],"coordinates":[{"x":"229.85","y":"545.26"},{"x":"88.67","y":"576.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_196","part":"s3v1","offsets":[{"start":2700,"text":"The severity of the reported URTIs was evaluated by  means  of  the  validated  Canadian  Acute  Respirator y Illness and Flu Scale (CARIFS) consisting of not only 18 items  including  illness-specific  questions  but  also  items"}],"coordinates":[{"x":"78.63","y":"670.26"},{"x":"289.15","y":"714.38"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_196","part":"s3v1","offsets":[{"start":2932,"text":"related  to  the  social  behaviour  and  general  mood  of  the child [9]."}],"coordinates":[{"x":"306.14","y":"57.76"},{"x":"344.47","y":"76.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_217","part":"s3v1","offsets":[{"start":3272,"text":"Descriptive statistics (number of observations, minimum and maximum values and standard deviation or standard error of the mean when this is specified) were used and evaluated using Fisher’s exact test for the analysis of the categorical endpoints, whereas Mann–Whitney U test/Wilcoxon rank sum test was applied for the analysis of the continuous vari-ables. Statistical calculations were performed using StatXact Version 10.1 and all presented p values are nominal, i.e. not adjusted for multiplicity. A p value less than 5% is consid-ered statistically significant."}],"coordinates":[{"x":"306.14","y":"182.76"},{"x":"419.01","y":"301.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_148","part":"s3v1","offsets":[{"start":4135,"text":"presented for the intention to treat (ITT)"}],"coordinates":[{"x":"338.81","y":"370.26"},{"x":"496.91","y":"376.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_166","part":"s3v1","offsets":[{"start":4190,"text":"In addition, a theoretical projection of the obtained results, to the aimed number of approximately 300 participants, was applied using each participant three times. It was assumed that the difference between the groups remained the same in the population of 300 children as obtained in the population of 99. Data on safety are presented for the ITT population only."}],"coordinates":[{"x":"306.14","y":"382.76"},{"x":"325.70","y":"464.38"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_177","part":"s3v1","offsets":[{"start":4805,"text":"In total, 25 children discontinued the study (11.4%) mostly due to parental withdrawal of informed consent"}],"coordinates":[{"x":"306.14","y":"582.76"},{"x":"494.47","y":"601.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_172","part":"s3v1","offsets":[{"start":4850,"text":"(11.4%) mostly due to parental withdrawal of informed consent."}],"coordinates":[{"x":"482.48","y":"582.76"},{"x":"496.98","y":"601.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_121","part":"s3v1","offsets":[{"start":5224,"text":"The two study groups did not differ at baseline regarding gender and age (Table 1)."}],"coordinates":[{"x":"510.37","y":"657.76"},{"x":"362.16","y":"689.38"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_121","part":"s4v1","offsets":[{"start":1966,"text":"Table 1   Baseline characteristics (ITT population)Total Probi  Defendum® PlaceboChildren randomised, n (%) 131 (100) 63 (48.1) 68 (51.9)Males, n (%) 75 (57.2) 32 (50.8) 43 (63.2)Females, n (%) 56 (42.7) 31 (49.2) 25 (36.8)Age in years. mean (SD) 3.1 ± 1.4 3.1 ± 1.4 3.1 ± 1.4 1–2 years old, n (%) 48 (36.6) 24 (38.1) 24 (35.3) 3–4 years old, n (%) 54 (41.2) 24 (38.1) 29 (42.6) 5–6 years old, n (%) 30 (22.9) 15 (23.8) 15 (22.1)"}],"coordinates":[{"x":"51.02","y":"284.18"},{"x":"288.63","y":"409.97"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_161","part":"s4v1","offsets":[{"start":2519,"text":"44 55"}],"coordinates":[{"x":"135.97","y":"492.14"},{"x":"229.53","y":"497.77"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_131","part":"s8v1","offsets":[{"start":5218,"text":"double-blind"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_131","part":"s9v1","offsets":[{"start":675,"text":"double-blind"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}}],"relations":[]}